Hap Trading, LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $5.49 Million - $7.93 Million	-48,400 Reduced 45.49%	58,000 $13.8 Million
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $9.97 Million - $15.1 Million	106,400 New	106,400 $621 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $2.62 Million - $3.87 Million	24,600 New	24,600 $2.82 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $1.19 Million - $1.56 Million	11,800 New	11,800 $151,000
Q2 2022 Aug 12, 2022	SELL	$62.69 - $88.44 $407,485 - $574,860	-6,500 Reduced 33.85%	12,700 $36,000
Q1 2022 May 12, 2022	SELL	$63.15 - $90.42 $644,130 - $922,284	-10,200 Reduced 34.69%	19,200 $64,000
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $293,664 - $377,796	-3,800 Reduced 11.45%	29,400 $178,000
Q3 2021 Nov 10, 2021	BUY	$65.97 - $92.48 $1.06 Million - $1.49 Million	16,100 Added 94.15%	33,200 $230,000
Q2 2021 Aug 11, 2021	SELL	$69.38 - $86.75 $1.39 Million - $1.74 Million	-20,100 Reduced 54.03%	17,100 $52,000
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $144,500 - $337,900	2,000 Added 5.68%	37,200 $83,000
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $678,024 - $965,196	-5,400 Reduced 13.3%	35,200 $846,000
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $1.06 Million - $1.43 Million	-8,300 Reduced 16.97%	40,600 $228,000
Q2 2020 Aug 10, 2020	BUY	$93.0 - $171.7 $4.55 Million - $8.4 Million	48,900 New	48,900 $955,000
Q1 2020 May 08, 2020	SELL	$82.38 - $131.64 $11.6 Million - $18.5 Million	-140,800 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $8.34 Million - $14.8 Million	109,000 Added 342.77%	140,800 $1.53 Million
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $8.21 Million - $17.7 Million	-112,700 Reduced 77.99%	31,800 $54,000
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $5.3 Million - $7.17 Million	47,200 Added 48.51%	144,500 $1.29 Million
Q1 2019 May 10, 2019	BUY	$106.67 - $151.68 $6.39 Million - $9.09 Million	59,900 Added 160.16%	97,300 $220,000
Q4 2018 Feb 12, 2019	BUY	$97.32 - $148.76 $194,640 - $297,520	2,000 Added 5.65%	37,400 $215,000
Q3 2018 Nov 09, 2018	SELL	$115.31 - $161.51 $1.38 Million - $1.94 Million	-12,000 Reduced 25.32%	35,400 $896,000
Q2 2018 Aug 13, 2018	BUY	$71.74 - $153.69 $480,657 - $1.03 Million	6,700 Added 16.46%	47,400 $1.48 Million
Q1 2018 May 11, 2018	BUY	$54.02 - $82.27 $43,216 - $65,816	800 Added 2.01%	40,700 $277,000
Q4 2017 Feb 09, 2018	BUY	$47.64 - $56.75 $709,836 - $845,575	14,900 Added 59.6%	39,900 $195,000
Q3 2017 Nov 08, 2017	BUY	$35.73 - $47.15 $893,249 - $1.18 Million	25,000	25,000 $106,000

Others Institutions Holding SRPT

# of Institutions

527

Shares Held

84.9M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.16 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.01 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$702 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$489 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$479 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.82B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account